Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirko Signorelli

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMC Bioinformatics|September 7, 2016
NEAT: an efficient network enrichment analysis testMirko Signorelli, Veronica Vinciotti, Ernst C Wit
Statistical Methods in Medical Research|January 10, 2024
Dynamic prediction of survival using multivariate functional principal component analysis: A strict landmarking approachDaniel Gomon, Hein Putter, Marta Fiocco, et al.
Plos One|March 31, 2023
Multiomic characterization of disease progression in mice lacking dystrophinMirko Signorelli, Roula Tsonaka, Annemieke Aartsma-Rus, et al.
Statistics in Medicine|August 31, 2021
Penalized regression calibration: A method for the prediction of survival outcomes using complex longitudinal and high-dimensional dataMirko Signorelli, Pietro Spitali, Cristina Al-Khalili Szigyarto, et al.
Human Molecular Genetics|February 7, 2020
Longitudinal metabolomic analysis of plasma enables modeling disease progression in Duchenne muscular dystrophy mouse modelsRoula Tsonaka, Mirko Signorelli, Ekrem Sabir, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 28, 2019
Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophyMirko Signorelli, Burcu Ayoglu, Camilla Johansson, et al.
Clinical Proteomics|June 12, 2023
Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkersCamilla Johansson, Helian Hunt, Mirko Signorelli, et al.
Neurology|February 27, 2023
Longitudinal Assessment of Creatine Kinase, Creatine/Creatinine<sub>ratio</sub>, and Myostatin as Monitoring Biomarkers in Becker Muscular DystrophyNienke M van de Velde, Zaïda Koeks, Mirko Signorelli, et al.
Journal of Neuromuscular Diseases|May 12, 2020
Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophyKristin Strandberg, Burcu Ayoglu, Andreas Roos, et al.
Pharmacological Research|June 15, 2020
Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular DystrophyStefano C Previtali, Teresa Gidaro, Jordi Díaz-Manera, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMC Bioinformatics|September 7, 2016
NEAT: an efficient network enrichment analysis testMirko Signorelli, Veronica Vinciotti, Ernst C Wit
Statistical Methods in Medical Research|January 10, 2024
Dynamic prediction of survival using multivariate functional principal component analysis: A strict landmarking approachDaniel Gomon, Hein Putter, Marta Fiocco, et al.
Plos One|March 31, 2023
Multiomic characterization of disease progression in mice lacking dystrophinMirko Signorelli, Roula Tsonaka, Annemieke Aartsma-Rus, et al.
Statistics in Medicine|August 31, 2021
Penalized regression calibration: A method for the prediction of survival outcomes using complex longitudinal and high-dimensional dataMirko Signorelli, Pietro Spitali, Cristina Al-Khalili Szigyarto, et al.
Human Molecular Genetics|February 7, 2020
Longitudinal metabolomic analysis of plasma enables modeling disease progression in Duchenne muscular dystrophy mouse modelsRoula Tsonaka, Mirko Signorelli, Ekrem Sabir, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 28, 2019
Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophyMirko Signorelli, Burcu Ayoglu, Camilla Johansson, et al.
Clinical Proteomics|June 12, 2023
Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkersCamilla Johansson, Helian Hunt, Mirko Signorelli, et al.
Neurology|February 27, 2023
Longitudinal Assessment of Creatine Kinase, Creatine/Creatinine<sub>ratio</sub>, and Myostatin as Monitoring Biomarkers in Becker Muscular DystrophyNienke M van de Velde, Zaïda Koeks, Mirko Signorelli, et al.
Journal of Neuromuscular Diseases|May 12, 2020
Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophyKristin Strandberg, Burcu Ayoglu, Andreas Roos, et al.
Pharmacological Research|June 15, 2020
Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular DystrophyStefano C Previtali, Teresa Gidaro, Jordi Díaz-Manera, et al.
Pageof 2